---
title: "Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/267891060.md"
description: "Gilead Sciences Inc. (GILD) stock fell 1.31% to $125.84 on Friday, underperforming compared to competitors. The S&P 500 Index rose 0.54% and the Dow Jones Industrial Average rose 0.61%. Gilead's stock ended a two-day winning streak and closed 2.22% below its 52-week high. Trading volume was 3.1 million, below the 50-day average of 7.6 million."
datetime: "2025-11-28T21:35:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267891060.md)
  - [en](https://longbridge.com/en/news/267891060.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267891060.md)
generator: "portal-rs"
---

# Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Gilead Sciences Inc. (GILD) slid 1.31% to $125.84 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,849.09 and the Dow Jones Industrial Average rising 0.61% to 47,716.42. The stock's fall snapped a two-day winning streak. Gilead Sciences Inc. closed 2.22% below its 52-week high of $128.70, which the company reached on November 20th. The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.31% to $206.92, Pfizer Inc. (PFE) rose 0.12% to $25.74, and Abbott Laboratories (ABT) rose 0.28% to $128.90. Trading volume (3.1 M) remained 4.5 million below its 50-day average volume of 7.6 M. Data source: Dow Jones Market Data, FactSet. Data compiled November 28, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-28-25 1635ET

### Related Stocks

- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)

## Related News & Research

- [Parallax Volatility Advisers L.P. Trims Holdings in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/297162579.md)
- [FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients](https://longbridge.com/en/news/297236507.md)
- [Target Is Up 66% This Year. Here's Whether the Dividend King Still Has Room to Run After Earnings.](https://longbridge.com/en/news/297430960.md)
- [Buying 30-year bonds? Locking in today's rates could hurt your retirement planning.](https://longbridge.com/en/news/297194547.md)
- [Bank of New York Mellon Corp Invests $31.95 Million in ACI Worldwide, Inc. $ACIW](https://longbridge.com/en/news/297416707.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**